Your session is about to expire
← Back to Search
IndieTrainer System for Cerebral Palsy
N/A
Waitlist Available
Research Sponsored by Grand Valley State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has a diagnosis of cerebral palsy or similar conditions with functional abilities consistent with a Gross Motor Classification System Classification System Level IV or Level V
Does not have an individually prescribed powered wheelchair
Must not have
The child and his/her manual wheelchair or adaptive stroller combined must weigh <300 pounds to safely use the IndieTrainer
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline-pre-intervention and immediately after the conclusion of the intervention period,
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the IndieTrainer system, which helps children with cerebral palsy practice using powered wheelchairs. The system converts their manual wheelchair and uses video games for training. It aims to make learning these skills easier and more fun.
Who is the study for?
This trial is for children aged 5-21 with cerebral palsy who can't move their manual wheelchair by themselves and don't have a power wheelchair. They must be using a manual wheelchair or stroller that fits the IndieTrainer system, and weigh less than 300 pounds combined with it. Children with progressive conditions like muscular dystrophy can't join.
What is being tested?
The study tests the IndieTrainer system, which turns a regular manual wheelchair into a powered one. It includes video games that help kids practice moving around in their wheelchairs while playing. The goal is to see if this makes it easier for them to learn how to use power wheelchairs.
What are the potential side effects?
Since this trial involves training equipment rather than medication, traditional side effects are not expected. However, there may be risks associated with using the adapted equipment such as discomfort or injury from improper use.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have cerebral palsy or a similar condition and need significant assistance with mobility.
Select...
I do not own a custom-made powered wheelchair.
Select...
I cannot move a manual wheelchair by myself.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My child and their wheelchair or stroller together weigh less than 300 pounds.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline-pre-intervention, immediately after the conclusion of the intervention period, and at the single session retention trial 4 weeks after the end of the intervention period
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline-pre-intervention, immediately after the conclusion of the intervention period, and at the single session retention trial 4 weeks after the end of the intervention period
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in power mobility skill performance
Change in power mobility skills performance
Change in understanding how to use a power mobility device
Secondary study objectives
Changes in perceptions regarding the IndieTrainer system intervention
Parent/caregiver satisfaction with the IndieTrainer system
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single arm: All participants receive the interventionExperimental Treatment1 Intervention
All participants receive power wheelchair skills training using the IndieTrainer system.
Research Highlights
Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The IndieTrainer system for Cerebral Palsy (CP) combines power mobility training with video games to enhance mobility and independence. This approach uses motor learning and neuroplasticity principles, where repetitive, task-specific training improves motor function and coordination.
Video games make the training engaging and motivating, crucial for sustained participation. Similar to physical and occupational therapy, which focus on improving motor skills, balance, and functional independence, these treatments significantly enhance quality of life by promoting autonomy, reducing care burden, and enabling participation in various activities.
Find a Location
Who is running the clinical trial?
Grand Valley State UniversityLead Sponsor
12 Previous Clinical Trials
8,654 Total Patients Enrolled
4 Trials studying Cerebral Palsy
48 Patients Enrolled for Cerebral Palsy
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My child and their wheelchair or stroller together weigh less than 300 pounds.I have a condition like spinal muscular atrophy that might get worse over time.I have cerebral palsy or a similar condition and need significant assistance with mobility.I do not own a custom-made powered wheelchair.I use a wheelchair or stroller that works with the IndieTrainer system.My caregiver or parent can speak English, as confirmed by the study leader.I cannot move a manual wheelchair by myself.
Research Study Groups:
This trial has the following groups:- Group 1: Single arm: All participants receive the intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger